These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 21339361)

  • 1. Protection of nonself surfaces from complement attack by factor H-binding peptides: implications for therapeutic medicine.
    Wu YQ; Qu H; Sfyroera G; Tzekou A; Kay BK; Nilsson B; Nilsson Ekdahl K; Ricklin D; Lambris JD
    J Immunol; 2011 Apr; 186(7):4269-77. PubMed ID: 21339361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-regulatory biomaterial coatings: Activity and selectivity profile of the factor H-binding peptide 5C6.
    Bechtler C; Koutsogiannaki S; Umnyakova E; Hamid A; Gautam A; Sarigiannis Y; Pouw RB; Lamers C; Rabbani S; Schmidt CQ; Lambris JD; Ricklin D
    Acta Biomater; 2023 Jan; 155():123-138. PubMed ID: 36328123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion.
    Amdahl H; Jongerius I; Meri T; Pasanen T; Hyvärinen S; Haapasalo K; van Strijp JA; Rooijakkers SH; Jokiranta TS
    J Immunol; 2013 Aug; 191(4):1775-84. PubMed ID: 23863906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement.
    Pangburn MK; Pangburn KL; Koistinen V; Meri S; Sharma AK
    J Immunol; 2000 May; 164(9):4742-51. PubMed ID: 10779780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new map of glycosaminoglycan and C3b binding sites on factor H.
    Schmidt CQ; Herbert AP; Kavanagh D; Gandy C; Fenton CJ; Blaum BS; Lyon M; Uhrín D; Barlow PN
    J Immunol; 2008 Aug; 181(4):2610-9. PubMed ID: 18684951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells.
    Barilla-LaBarca ML; Liszewski MK; Lambris JD; Hourcade D; Atkinson JP
    J Immunol; 2002 Jun; 168(12):6298-304. PubMed ID: 12055245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
    Blom AM; Kask L; Dahlbäck B
    Mol Immunol; 2003 Jan; 39(10):547-56. PubMed ID: 12431388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A; Isaacs SN; Soulika AM; Lambris JD
    J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
    Sahu A; Kay BK; Lambris JD
    J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces.
    Ferreira VP; Herbert AP; Hocking HG; Barlow PN; Pangburn MK
    J Immunol; 2006 Nov; 177(9):6308-16. PubMed ID: 17056561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sulphated polyanions on functions of complement factor H.
    Koistinen V
    Mol Immunol; 1993 Feb; 30(2):113-8. PubMed ID: 8429830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups on nonactivating surfaces.
    Carreno MP; Labarre D; Maillet F; Jozefowicz M; Kazatchkine MD
    Eur J Immunol; 1989 Nov; 19(11):2145-50. PubMed ID: 2480904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational engineering of a minimized immune inhibitor with unique triple-targeting properties.
    Schmidt CQ; Bai H; Lin Z; Risitano AM; Barlow PN; Ricklin D; Lambris JD
    J Immunol; 2013 Jun; 190(11):5712-21. PubMed ID: 23616575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.
    McRae JL; Duthy TG; Griggs KM; Ormsby RJ; Cowan PJ; Cromer BA; McKinstry WJ; Parker MW; Murphy BF; Gordon DL
    J Immunol; 2005 May; 174(10):6250-6. PubMed ID: 15879123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement control protein factor H: the good, the bad, and the inadequate.
    Ferreira VP; Pangburn MK; Cortés C
    Mol Immunol; 2010 Aug; 47(13):2187-97. PubMed ID: 20580090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
    Brown EJ; Joiner KA; Gaither TA; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses.
    Xue X; Wu J; Ricklin D; Forneris F; Di Crescenzio P; Schmidt CQ; Granneman J; Sharp TH; Lambris JD; Gros P
    Nat Struct Mol Biol; 2017 Aug; 24(8):643-651. PubMed ID: 28671664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel and sensitive functional assay for complement Factor I based on the third proteolytic clip of C3b.
    Lachmann PJ; Lay E; Seilly DJ
    J Immunol Methods; 2018 Jun; 457():30-32. PubMed ID: 29625075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attachment of the soluble complement regulator factor H to cell and tissue surfaces: relevance for pathology.
    Józsi M; Manuelian T; Heinen S; Oppermann M; Zipfel PF
    Histol Histopathol; 2004 Jan; 19(1):251-8. PubMed ID: 14702193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group A streptococcal phagocytosis resistance is independent of complement factor H and factor H-like protein 1 binding.
    Kotarsky H; Gustafsson M; Svensson HG; Zipfel PF; Truedsson L; Sjöbring U
    Mol Microbiol; 2001 Aug; 41(4):817-26. PubMed ID: 11532146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.